News PharmAla Biotech receives guidance on new MDMA-like drug for PTSD and Autism The MHRA has confirmed that PharmAla's MDMA-like drug candidate ALA-002 does not require additional preclinical data Natalia Buendia CalvilloJuly 20, 2023